Related Experiment Videos

Insights

A 1981 study on Meniere's disease found that endolymphatic sac mastoid shunts offered no significant benefit over placebo surgery. Long-term results confirm that symptom improvement in both groups was likely due to the placebo effect.

Area of Science:

  • Otolaryngology
  • Neurosurgery
  • Clinical Trials

Background:

  • Meniere's disease is a disorder of the inner ear affecting balance and hearing.
  • Endolymphatic sac shunts were a surgical option to manage Meniere's disease symptoms.
  • Previous studies suggested potential efficacy of surgical interventions.

Purpose of the Study:

  • To compare the efficacy of endolymphatic sac mastoid shunts versus a placebo (mastoidectomy) in treating Meniere's disease.
  • To assess the long-term effectiveness of the shunt procedure.
  • To determine if surgical intervention provides specific benefits beyond a placebo response.

Main Methods:

  • A double-blind, placebo-controlled study involving 30 patients with Meniere's disease.
  • Comparison of endolymphatic sac mastoid shunt surgery against a sham mastoidectomy procedure.
  • Preoperative and postoperative symptom scoring for both treatment groups.
  • Follow-up evaluation at 1 year and extended to a minimum of 3 years.

Main Results:

  • Both the shunt group and the placebo group showed significant improvement in Meniere's disease symptoms.
  • No statistically significant difference in symptom control was observed between the shunt and the placebo surgery.
  • The observed improvements were consistent across the 1-year and 3-year follow-up periods.

Conclusions:

  • The effectiveness of endolymphatic sac shunts for Meniere's disease symptoms appears to be nonspecific.
  • The significant symptom improvement in both groups strongly suggests a substantial placebo effect.
  • Surgical interventions for Meniere's disease may not offer specific therapeutic advantages over placebo.

Related Concept Videos